A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine

NCT03755427 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

560

Enrollment

INDUSTRY

Sponsor class

Conditions

H7N9 Influenza

Interventions

BIOLOGICAL: 15μg H7N9 Vaccine
BIOLOGICAL: Aluminum Hydroxide Adjuvant

Sponsor

Shanghai Institute Of Biological Products